343 related articles for article (PubMed ID: 38613348)
41. Hippo Signaling in Embryogenesis and Development.
Wu Z; Guan KL
Trends Biochem Sci; 2021 Jan; 46(1):51-63. PubMed ID: 32928629
[TBL] [Abstract][Full Text] [Related]
42. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract][Full Text] [Related]
43. The Hippo pathway in tissue homeostasis and regeneration.
Wang Y; Yu A; Yu FX
Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
[TBL] [Abstract][Full Text] [Related]
44. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
Cho YS; Jiang J
Front Cell Dev Biol; 2021; 9():658481. PubMed ID: 33869224
[TBL] [Abstract][Full Text] [Related]
45. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
Miesfeld JB; Link BA
Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
[TBL] [Abstract][Full Text] [Related]
46. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
Deng F; Wu Z; Zou F; Wang S; Wang X
Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
[TBL] [Abstract][Full Text] [Related]
47. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
48. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
49. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Wang J; Liu S; Heallen T; Martin JF
Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
[TBL] [Abstract][Full Text] [Related]
50. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
51. Neuronal Hippo signaling: From development to diseases.
Sahu MR; Mondal AC
Dev Neurobiol; 2021 Mar; 81(2):92-109. PubMed ID: 33275833
[TBL] [Abstract][Full Text] [Related]
52. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
Wang J; Martin JF
J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
[TBL] [Abstract][Full Text] [Related]
53. Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers.
Luo M; Xu Y; Chen H; Wu Y; Pang A; Hu J; Dong X; Che J; Yang H
Eur J Med Chem; 2022 Dec; 244():114847. PubMed ID: 36265280
[TBL] [Abstract][Full Text] [Related]
54. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
[TBL] [Abstract][Full Text] [Related]
55. The Roles of NDR Protein Kinases in Hippo Signalling.
Hergovich A
Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
[TBL] [Abstract][Full Text] [Related]
56. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy.
Berecz T; Yiu A; Vittay O; Orsolits B; Mioulane M; Dos Remedios CG; Ketteler R; Merkely B; Apáti Á; Harding SE; Hellen N; Foldes G
ESC Heart Fail; 2022 Feb; 9(1):224-235. PubMed ID: 34931757
[TBL] [Abstract][Full Text] [Related]
58. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression.
Messina B; Lo Sardo F; Scalera S; Memeo L; Colarossi C; Mare M; Blandino G; Ciliberto G; Maugeri-Saccà M; Bon G
Cell Death Dis; 2023 Jan; 14(1):21. PubMed ID: 36635265
[TBL] [Abstract][Full Text] [Related]
59. In Situ Cell Signalling of the Hippo-YAP/TAZ Pathway in Reaction to Complex Dynamic Loading in an Intervertebral Disc Organ Culture.
Croft AS; Roth Y; Oswald KAC; Ćorluka S; Bermudez-Lekerika P; Gantenbein B
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948441
[TBL] [Abstract][Full Text] [Related]
60. The role of the Hippo pathway in autophagy in the heart.
Maejima Y; Zablocki D; Nah J; Sadoshima J
Cardiovasc Res; 2023 Jan; 118(17):3320-3330. PubMed ID: 35150237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
